Swiss National Bank Nevro Corp Transaction History

Swiss National Bank

$150 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$7.96 - $13.59 $27,860 - $47,565	-3,500 Reduced 5.43%	60,900 $512,000
Q1 2024 May 07, 2024	SELL	$13.56 - $20.78 $92,208 - $141,304	-6,800 Reduced 9.55%	64,400 $929,000
Q4 2023 Feb 06, 2024	SELL	$14.18 - $22.31 $107,768 - $169,556	-7,600 Reduced 9.64%	71,200 $1.53 Million
Q3 2023 Nov 08, 2023	BUY	$18.22 - $25.85 $18,220 - $25,850	1,000 Added 1.29%	78,800 $1.51 Million
Q2 2023 Aug 09, 2023	BUY	$22.62 - $39.32 $117,624 - $204,464	5,200 Added 7.16%	77,800 $1.98 Million
Q1 2023 May 10, 2023	SELL	$30.17 - $41.11 $256,445 - $349,435	-8,500 Reduced 10.48%	72,600 $2.62 Million
Q4 2022 Feb 08, 2023	BUY	$36.43 - $49.4 $61,931 - $83,980	1,700 Added 2.14%	81,100 $3.21 Million
Q3 2022 Nov 09, 2022	BUY	$40.66 - $53.03 $36,594 - $47,727	900 Added 1.15%	79,400 $3.7 Million
Q1 2022 May 09, 2022	BUY	$59.95 - $92.06 $329,725 - $506,330	5,500 Added 7.53%	78,500 $5.68 Million
Q3 2021 Nov 08, 2021	BUY	$101.99 - $166.36 $50,995 - $83,180	500 Added 0.69%	73,000 $8.5 Million
Q2 2021 Aug 06, 2021	SELL	$141.6 - $179.06 $325,680 - $411,838	-2,300 Reduced 3.07%	72,500 $12 Million
Q1 2021 May 07, 2021	BUY	$132.81 - $182.18 $146,091 - $200,398	1,100 Added 1.49%	74,800 $10.4 Million
Q4 2020 Feb 05, 2021	BUY	$138.17 - $184.34 $69,085 - $92,170	500 Added 0.68%	73,700 $12.8 Million
Q3 2020 Nov 09, 2020	BUY	$114.09 - $145.51 $650,313 - $829,407	5,700 Added 8.44%	73,200 $10.2 Million
Q2 2020 Aug 05, 2020	BUY	$89.45 - $129.85 $661,930 - $960,890	7,400 Added 12.31%	67,500 $8.06 Million
Q1 2020 May 08, 2020	BUY	$70.23 - $144.31 $70,230 - $144,310	1,000 Added 1.69%	60,100 $6.01 Million
Q4 2019 Feb 06, 2020	BUY	$76.41 - $117.54 $129,897 - $199,818	1,700 Added 2.96%	59,100 $6.95 Million
Q3 2019 Nov 12, 2019	BUY	$61.52 - $91.1 $55,368 - $81,990	900 Added 1.59%	57,400 $4.94 Million
Q2 2019 Aug 02, 2019	BUY	$58.04 - $66.99 $406,280 - $468,929	7,000 Added 14.14%	56,500 $3.66 Million
Q1 2019 May 10, 2019	BUY	$35.52 - $62.62 $56,832 - $100,192	1,600 Added 3.34%	49,500 $3.09 Million
Q4 2018 Feb 13, 2019	BUY	$35.43 - $56.29 $42,516 - $67,548	1,200 Added 2.57%	47,900 $1.86 Million
Q2 2018 Aug 09, 2018	BUY	$72.38 - $92.5 $405,328 - $518,000	5,600 Added 13.63%	46,700 $3.73 Million
Q1 2018 May 04, 2018	BUY	$69.46 - $88.57 $69,460 - $88,570	1,000 Added 2.49%	41,100 $3.56 Million
Q4 2017 Feb 07, 2018	BUY	$65.94 - $93.31 $79,128 - $111,972	1,200 Added 3.08%	40,100 $2.77 Million
Q3 2017 Nov 03, 2017	BUY	$80.87 - $91.08 $3.15 Million - $3.54 Million	38,900	38,900 $3.54 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$16.6 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.1 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$13.6 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.26 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$7.94 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $134M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account